- FDA approved indications in adults
- Rheumatoid Arthritis
- Osteoarthritis
- Analgesic in mild to moderate pain
- See Salicylate
- See Salicylate
- Difluorophenyl derivate of salicylic acid
- Unlike other Salicylates, Diflunisal is not metabolized to salicylic acid
- Results in a longer Half-Life than for other Salicylates
- As with other Salicylates and NSAIDs, has antipyretic, Analgesic and anti-inflammatory properties
- Blocks cyclooxygenase (COX, esp. COX1)
- Inhibits conversion of Arachidonic Acid to Prostaglandin precursors
- Decreasing Prostaglanding levels results in decreased pain, inflammation and fever
- Diflunisal 250 to 500 mg orally every 8 to 12 hours
- Maximum: 1500 mg/day
- See Salicylate
- See Salicylate
- Avoid in Lactation